Emergence of carbapenem-resistant klebsiella pneumoniae strains producing KPC-3 in brescia hospital, italy

New Microbiologica

Volumn 37, Issue 2, 2014, Pages 177-183

  Corbellini, Silvi ^a   Caccuri, Francesc ^a   Gelmi, Marin ^a   De Francesco, Maria Antonia ^a   Fiorentini, Simon ^a   Caruso, Arnald ^a   Giagulli, Cinzi ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

Author keywords

BlaKPC; Carbapenem resistant; DiversiLab; Klebsiella pneumonia; KPC 3; Multidrug resistant

Indexed keywords

ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; BETA LACTAMASE; CARBAPENEM DERIVATIVE; CARBAPENEMASE;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; CLASSIFICATION; CROSS INFECTION; DRUG EFFECT; ENZYMOLOGY; FEMALE; GENETICS; HOSPITAL; HUMAN; ISOLATION AND PURIFICATION; ITALY; KLEBSIELLA INFECTION; KLEBSIELLA PNEUMONIAE; MALE; METABOLISM; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MIDDLE AGED; PHYLOGENY; STATISTICS; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BETA-LACTAMASES; CARBAPENEMS; CROSS INFECTION; DRUG RESISTANCE, BACTERIAL; FEMALE; HOSPITALS; HUMANS; ITALY; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PHYLOGENY; YOUNG ADULT;

EID: 84900446906     PISSN: 11217138     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Alba J., Ishii Y., Thomson K., Moland E. S., Yamaguchi K. (2005). Kinetics study of KPC-3, a plasmidencoded class A carbapenem-hydrolyzing betalactamase. Antimicrob. Agents Chemother. 49, 4760-4762.
2. Anderson K. F. (2007). Evaluation of methods to identify the Klebsiella pneumoniae carbapenemase in Enterobacteriaceae. J. Clin. Microbiol. 45, 2723-2725.
3. Bingen E. H., Desjardins P., Arlet G., Bourgeois F., Mariani-Kurkdjian P., et al. (1993). Molecular epidemiology of plasmid spread among extended broad-spectrum beta-lactamase-producing Klebsiella pneumoniae isolates in a pediatric hospital. J. Clin. Microbiol. 31, 179-184.
4. Bonacorsi S., Bidet P., Mahjoub F., Mariani-Kurkdjian P., Ait-Ifrane S., et al. (2009). Semi-automated rep-PCR for rapid differentiation of major clonal groups of Escherichia coli meningitis strains. Int. J. Med. Microbiol. 299, 402-409.
5. Brolund A., Hæggman S., Edquist P. J., Gezelius L., Olsson-Liljequist B., et al. (2010). The Diversi- Lab system versus pulsed-field gel electrophoresis: characterisation of extended spectrum ?-lactamase producing Escherichia coli and Klebsiella pneumoniae. J. Microbiol. Methods. 83, 224-230.
6. Bulik C. C., Fauntleroy K. A., Jenkins S. G, Abuali M., La Bombardi V. J., et al. (2010). Comparison of meropenem MICs and susceptibilities for carbapenemase- producing Klebsiella pneumoniae isolates by various testing methods. J. Clin. Microbiol. 48, 2402-2406.
7. Cant ón R., Akòva M., Carmeli Y., Giske C. G., Glupczyn ski Y., et al. (2012). Rapid evolution and spread of carbapenemases amoung Enterobacteriaceae in Europe. J. Clin. Microbiol. Infect. 18, 413-431.
8. Casewell M., Phillips I. (1977). Hands as route of transmission for Klebsiella species. J. Br. Med. 2, 1315-1317.
9. Chen L., Mediavilla J. R., Endimiani A., Rosenthal M. E., Zhao Y., et al. (2011). Multiplex real-time PCR assay for detection and classification of Klebsiella pneumoniae carbapenemase gene (bla KPC) variants. J. Clin. Microbiol. 49, 579-585.
10. Chuang Y. C., Wang J. T., Chen M. L., Chen Y. C. (2010). Comparison of an automated repetitive-sequencebased PCR microbial typing system with pulsedfield gel electrophoresis for molecular typing of vancomycin-resistant Enterococcus faecium. J. Clin. Microbiol. 48, 2897-2901.
11. Falagas M. E., Kastoris A. C., Kapaskelis A. M., Karageorgopoulos D. E. (2010). Fosfomycin for the treatment of multidrug-resistant, including extended-spectrum ?-lactamase-producing, Enterobacteriaceae infections: a systematic review. Lancet Infect. Dis. 6, 43-50.
12. Fluit A. C. (2010). Evaluation of the DiversiLab system for detection of hospital outbreaks of infections by different bacterial species. J. Clin. Microbiol. 48, 3979-3989.
13. Giske C. G., Martinez-Martinez L., Canton R. (2012). EUCAST guidelines for detection of resistance mechanisms and specific resistances of clinical and/or epidemiological importance. Eucast. 4, 1-47.
14. Gupta N., Limbago B. M., Patel J. B., Kallen A. J. (2011). Carbapenem-resistant enterobacteriaceae: epidemiology and prevention. Clin. Infect. Dis. 53, 60-67.
15. Healy M., Huong J., Bittner T., Lising M., Frye S., et al. (2005). Microbial DNA typing by automated repetitive-sequence-based PCR. J. Clin. Microbiol. 43, 199-207.
16. Li J., Nation R. L., Turnidge J. D., Coulthard K., Rayner C. R., et al. (2006). Colistin: thereemerging antibiotic for multidrug-resistant Gram-negative bacterial infections. Lancet Infect. Dis. 6, 589-601
17. Ligozzi M., Fontana R., Aldegheri M., Scalet G., Lo Cascio G. (2010). Comparative evaluation of an automated repetitive-sequence-based PCR instrument versus pulsed-field gel electrophoresis in the setting of a Serratia marcescens nosocomial infection outbreak. J. Clin. Microbiol. 48, 1690-1695.
18. Livermore D. M., Warner M., Mushtaq S., Mushtaq S., Doumith M., et al. (2011). What remains against carbapenem-resistant Enterobacteriaceae? Evaluation of chloramphenicol, ciprofloxacin, colistin, fosfomycin, minocycline, nitrofurantoin, temocillin and tigecycline. J. Antimicrob. Agents. 37, 415-419.
19. Livermore D. M. (2005). Tigecycline: what is it, and where should it be used? J. Antimicrob. Chemother. 56, 611-614.
20. Livermore D. M. (2012). Current epidemiology and growing resistance of gram-negative pathogens. Korean J. Intern. Med. 27, 128-142.
21. Marschall J., Tibbetts R. J., Dunne W. M., Frye J. G., Fraser V. J., et al. (2009). Presence of the KPC carbapenemase gene in Enterobacteriaceae causing bacteremia and its correlation with in vitro carbapenem susceptibility. J. Clin. Microbiol. 47, 239-241.
22. Migliavacca R., Nucleo E., Asticcioli S., Casari E., Bracco S., et al. (2013). Multifocal diffusion of a KPC-3 producing ST512 K. pneumoniae clone in Northen Italy. New Microbiol. 36, 109-110.
23. Nordmann P., Cuzon G., Naas T. (2009). The real threat of Klebsiella pneumoniae carbapenemaseproducing bacteria. Lancet Infect. Dis. 9, 228-236.
24. Patel G., Huprikar S., Factor S. H., Jenk ins S. G., Calfee D. P. (2008). Outcomes of CRKP infection and the impact of antimicrobial and adjunctive therapies. Infect. Control. Hosp. Epidemiol. 29, 1099-1106.
25. Podschun R., Ullmann U. (1998). Klebsiella spp. As nosocomial pathogens: epidemiology, taxonomy, typing methods, and pathogenicity factors. Clin. Microbiol. Rev. 11, 589-603.
26. Poh C. L., Yap S. C., Yeo M. (1993). Pulsed-field gel electrophoresis for differentiation of hospital isolates of Klebsiella pneumoniae. J. Hosp. Infect. 24, 123-128.
27. Rodriguez-Martinez J. M., Poirel L., Nordmann P. (2009). Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 53, 4783-4788.
28. Selden R., Lee S., Wang W. L. L., Bennet J. V. Eickhoff T. C. (1971). Nosocomial Klebsiella infections: Intestinal colonization as a reservoir. Ann. Intern. Med. 74, 657-664.
29. Sisto A., D'Ancona F., Meledandri M., Pantosti A., Rossolini G. M., et al. (2009). Carbapenem nonsusceptible Klebsiella pneumoniae from Micronet network hospitals, Italy, to 2012. Euro Surveill. 1, 16-17.
30. Sundin D. P., Sandoval R., Molitoris B. A. (2001). Gentamicin inhibits renal protein and phospholipid metabolism in rats: implications involving intracellular trafficking. J. Am. Soc. Nephrol. 12, 114-123.
31. Tenover F. C., Kalsi R. K., Williams P. P. Carey R. B., Stocker S., et al. (2006). Carbapenem resistance in Klebsiella pneumoniae not detected by automated susceptibility testing. Emerg. Infect. Dis. 12, 1209-1210.
32. Wiener-Well Y., Rudensky B., Yinnon A. M., Kopuit P., Schlesinger Y., et al. (2010). Carriage rate of CRKP in hospitalised patients during a National out break. J. Infect. 74, 344-349.
33. Wolter D. J. (2009). Phenotypic and enzymatic comparative analysis of the novel KPC variant KPC-5 and its evolutionary variants, KPC-2 and KPC-4. Antimicrob. Agents C. Chemother. 53, 557-562.